Recent developments
Biopharma elastomer scrutiny
Regulators now expect elastomer closures in biosimilars to match originators on functional suitability, E&L, and CCI, increasing diligence on format migration and dual‑market filings. In medical tubing, Mitsubishi Chemical’s medical‑grade thermoplastic styrenic elastomer ZELAS TPS enables closed‑loop cell culture with heat‑sealing and sterilization compatibility, accelerating moves from PVC to sterilizable TPEs.
Asian R&D buildout
Asian polymer R&D and capacity advanced. Evonik opened the Asia PAthletic Center in Shanghai for PA12/PEBAs, and its PA12 polymerization reactor in Shanghai began trials, doubling regional long‑chain polyamide. ARLANXEO launched the Innovation Center Asia in Changzhou beside EPDM/HNBR lines. Arkema added a Rilsan Clear unit in Singapore. Sinopec signed a strategic cooperation agreement with Amcor at Chinaplas.
Sports and mobility materials
Footwear and mobility materials evolved. BASF launched the Elastollan GripTec TPU outsole portfolio for traction and abrasion with a lower reported manufacturing‑stage footprint than rubber. Arkema showcased Pebax thermoplastic elastomers and Rilsan PA11 for consumer goods and lower‑carbon mobility.
Strategic shifts and stress
Corporate shifts reshaped supply. SABIC reported Q1 improvement and an agreement with the PIF‑Pirelli joint venture to enable 3.5 million tyres/year; Dr. Faisal Alfaqeer took office as CEO of SABIC. ARLANXEO will market PRC‑produced EPDM under the Keltan KSA brand exclusively. Trinseo’s debt waivers expired, indicating creditor‑led restructuring and likely European divestments.
Feedstocks and sustainability
Feedstocks and sustainability progressed. Vega Ploieşti began producing normal hexane at 60% purity for adhesives and rubber extraction. Mitsui Chemicals gained ISCC PLUS for ACTCOL. Elkem launched eco‑designed PURESIL elastomer grades using a sunflower‑derived carrier. European energy exposure remained a structural risk per BASF’s Verbund analysis.